The table below shows Anbio Biotechnology's income statement line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
Revenue
$8.65M
$8.19M
$6.71M
$23.54M
Cost of revenue
$1.10M
$2.30M
$3.35M
$10.98M
Gross profit
$7.54M
$5.89M
$3.36M
$12.56M
R&D
$201.31K
$454.23K
$134.70K
$200.00K
SG&A
$1.57M
$3.44M
$1.27M
$2.17M
Operating income
$5.77M
$2.00M
$1.96M
$10.20M
NNNN annual revenue (10-K history)
Anbio Biotechnology reported annual revenue of $8.65M for fiscal year 2025. That is up 5.6% from $8.19M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.